Publication Cover
Redox Report
Communications in Free Radical Research
Volume 22, 2017 - Issue 5
1,519
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Oxidative stress in otosclerosis

, , , , , , , , & show all

References

  • Rudić M, Milković L, Žarković K, Borović-Šunjić S, Sterkers O, Waeg G, et al. The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis. Free Radic Biol Med 2013;57:22–8. doi: 10.1016/j.freeradbiomed.2012.11.023
  • Richard C, Doherty JK, Fayad JN, Cordero A, Linthicum FH Jr. Identification of target proteins involved in cochlear otosclerosis. Otol Neurotol 2015;36(5):923–31. doi: 10.1097/MAO.0000000000000680
  • Declau F, van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, et al. Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians. Adv Otorhinolaryngol 2007;65:6–16. doi:10.1159/000098663.
  • Baysal E, Aksoy N, Kara F, Taysi S, Taşkın A, Bilinç H, et al. Oxidative stress in chronic otitis media. Eur Arch Otorhinolaryngol 2013;270(4):1203–8. doi: 10.1007/s00405-012-2070-z
  • Taysi S, Memisogullari R, Koc M, Yazici AT, Aslankurt M, Gumustekin K, et al. Melatonin reduces oxidative stress in the rat lens due to radiation-induced oxidative injury. Int J Radiat Biol 2008;84(10):803–8. doi: 10.1080/09553000802390932
  • Okumus S, Taysi S, Orkmez M, Saricicek E, Demir E, Adli M, et al. The effects of oral Ginkgo biloba supplementation on radiation-induced oxidative injury in the lens of rat. Pharmacogn Mag 2011;7(26):141–5. doi: 10.4103/0973-1296.80673
  • Zengin S, Behcet A, Karta S, Can B, Orkmez M, Taskin A, et al. An assessment of antioxidant status in patients with carbon monoxide poisoning. World J Emerg Med 2014;5(2):91–5. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.002
  • Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of Lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286(1–2):152–4. doi: 10.1016/0014-5793(91)80962-3
  • Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/ arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126–38.
  • Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007;191(2):397–402. doi: 10.1016/j.atherosclerosis.2006.04.007
  • Cakmak A, Zeyrek D, Atas A, Selek S, Erel O. Oxidative status and paraoxonase activity in children with asthma. Clin Invest Med 2009;32(5):E327–34.
  • Yilmaz T, Koçan EG, Besler HT. The role of oxidants and antioxidants in chronic tonsillitis and adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol 2004;68(8):1053–8. doi: 10.1016/j.ijporl.2004.04.003
  • Schulpis KH, Barzeliotou A, Papadakis M, Rodolakis A, Antsaklis A, Papassotiriou I, et al. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities. Clin Biochem 2008;41(4–5):282–7. doi: 10.1016/j.clinbiochem.2007.10.013
  • Selek S, Cosar N, Kocyigit A, Erel O, Aksoy N, Gencer M, et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 2008;41(3):140–4. doi: 10.1016/j.clinbiochem.2007.11.018
  • Baysal E, Taysi S, Aksoy N, Uyar M, Çelenk F, Karatas ZA, et al. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Eur Rev Med Pharmacol Sci 2012;16(6):770–74.
  • Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30(7):391–5. doi:10.1515/cclm.1992.30.7.391.
  • Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–9. doi: 10.1016/j.clinbiochem.2003.10.014
  • Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007;27(4):339–44. doi: 10.1007/s00296-006-0247-8
  • Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58–62. doi: 10.1016/S0076-6879(99)00113-5
  • Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998;44(11):2313–9.
  • Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70–7. doi: 10.1016/0003-9861(59)90090-6
  • Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993;121(2):257–62.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–11. doi: 10.1016/j.clinbiochem.2005.08.008
  • Harma M, Harma M, Kocyıgıt A, Erel O. Increased DNA damage in patients with complete hydatidiform mole. Mutat Res 2005;583(1):49–54. doi: 10.1016/j.mrgentox.2005.01.014
  • Ece A, Atamer Y, Gürkan F, Davutoğlu M, Bilici M, Tutanç M. Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol 2006;21(2):239–45. doi: 10.1007/s00467-005-2079-2
  • Çakmak A, Zeyrek D, Atas A, Selek S, Erel O. Oxidative status and paraoxonase activity in children with asthma. Clin Invest Med 2009;32(5):E327–34.
  • Shih DM, Lusis AJ. The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Curr Opin Lipidol 2009;20(4):288–92. doi: 10.1097/MOL.0b013e32832ca1ee
  • Tanimoto N, Kumon Y, Suehiro T, Ohkubo S, Ikeda Y, Nishiya K, et al. Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 2003;72(25):2877–85. doi: 10.1016/S0024-3205(03)00195-4
  • Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009;27(3):176–18. doi: 10.1002/cbf.1553
  • Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M. Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 2004;88(10):1256–8. doi: 10.1136/bjo.2004.043398
  • Shigemi H, Egashira T, Kurono Y, Mogi G. Role of superoxide dismutase in otitis media with effusion. Ann Otol Rhinol Laryngol 1998;107(4):327–31. doi: 10.1177/000348949810700411
  • Yariktas M, Doner F, Dogru H, Yasan H, Delibas N. The role of free oxygen radicals on the development of otitis media with effusion. Int J Pediatr Otorhinolaryngol 2004;68(7):889–94. doi: 10.1016/j.ijporl.2004.02.002
  • Hamzei M, Ventriglia G, Hagnia M, Antonopolous A, Bernal-Sprekelsen M, Dazert S, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 2003;113(3):436–42. doi: 10.1097/00005537-200303000-00009
  • Chole RA, Mckenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001;22(2):249–57. doi: 10.1097/00129492-200103000-00023
  • Menger DJ, Tange RA. The aetiology of otosclerosis: a review of the literature. Clin Otolaryngol Allied Sci 2003;28(2):112–20. doi: 10.1046/j.1365-2273.2003.00675.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.